NCO-48 Fumarate
NCO48F-01
Phase 1 small_molecule completed
Quick answer
NCO-48 Fumarate for Hepatitis B is a Phase 1 program (small_molecule) at LIGAND PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LIGAND PHARMACEUTICALS INC
- Indication
- Hepatitis B
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed